Advocates petitioned health officials to add the two new qualifications, as well as several other diagnoses – such as anxiety – that regulators ultimately rejected. Health officials also denied requests to expand the program to permit patients to access whole-plant cannabis or edibles. Under existing law, qualified patients may only access cannabis-infused oils.
Patients with autism and/or sleep apnea will be eligible to participate in the program beginning on July 1, 2018.
For more information, contact Justin Strekal, NORML Political Director, at (202) 483-5500.